Clinical trial
AngelMed for Early Recognition and Treatment of STEMI
NCT00781118 · Angel Medical Systems, Industry · Completed
Key facts
| NCT number | NCT00781118 |
|---|---|
| Title | AngelMed for Early Recognition and Treatment of STEMI |
| Official title | AngelMed for Early Recognition and Treatment of STEMI |
| Acronym | ALERTS |
| Lead sponsor | Angel Medical Systems, Industry |
| Collaborators | Symbios Clinical |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Myocardial Infarction (AMI), Coronary Occlusion, Acute Coronary Syndrome |
| Intervention type | Device |
| Interventions | Guardian System |
| Enrollment | 1,020 |
| Start date | Dec 1, 2008 |
| Primary completion | May 1, 2014 |
| Completion | May 17, 2017 |
| First posted | Oct 28, 2008 |
| Last update posted | Mar 14, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: